195 related articles for article (PubMed ID: 27283171)
1. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?
Jain R; Savage MJ; Forman AD; Mukherji R; Hall MJ
J Natl Compr Canc Netw; 2016 Jun; 14(6):795-806. PubMed ID: 27283171
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling in oncology clinical practice.
Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
[TBL] [Abstract][Full Text] [Related]
3. Understanding perceptions of tumor genomic profile testing in Black/African American cancer patients in a qualitative study: the role of medical mistrust, provider communication, and family support.
Luck CC; Bass SB; Chertock Y; Kelly PJA; Singley K; Hoadley A; Hall MJ
J Community Genet; 2024 Jun; 15(3):281-292. PubMed ID: 38366313
[TBL] [Abstract][Full Text] [Related]
4. Oncologists' perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients.
Hall MJ; D'Avanzo PA; Chertock Y; Kelly PJA; Brajuha J; Singley K; Luck CC; Bass SB
BMC Cancer; 2024 Apr; 24(1):412. PubMed ID: 38566032
[TBL] [Abstract][Full Text] [Related]
5. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
6. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
7. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Somatic and Germline Variant Interpretation in Hereditary Cancer Genes.
Moody EW; Vagher J; Espinel W; Goldgar D; Hagerty KJ; Gammon A
JCO Precis Oncol; 2019 Dec; 3():1-8. PubMed ID: 35100725
[TBL] [Abstract][Full Text] [Related]
9. "Somatic" Tumor Genomic Profiling and Potential Germline Implications: Ethical Considerations for Children with Cancer.
Knapp E
J Law Med Ethics; 2020 Dec; 48(4):778-783. PubMed ID: 33404327
[No Abstract] [Full Text] [Related]
10. Integration of Genomic Profiling and Organoid Development in Precision Oncology.
Yoon H; Lee S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008642
[TBL] [Abstract][Full Text] [Related]
11. Oncologists' Perceptions of Tumor Genomic Profiling and the Communication of Test Results and Risks.
Hall MJ; D'Avanzo P; Chertock Y; Brajuha J; Bass SB
Public Health Genomics; 2021; 24(5-6):304-309. PubMed ID: 34325422
[TBL] [Abstract][Full Text] [Related]
12. Recent Advancements and Innovations in Pediatric Precision Oncology.
Mangum R; Lin FY; Parsons DW
J Pediatr Hematol Oncol; 2024 Jul; 46(5):262-271. PubMed ID: 38857189
[TBL] [Abstract][Full Text] [Related]
13. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
[TBL] [Abstract][Full Text] [Related]
14. Genomic Medicine Takes the Stage, Again!
Tempero M
J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
[No Abstract] [Full Text] [Related]
15. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
16. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
[TBL] [Abstract][Full Text] [Related]
17. Precision oncology: Charting a path forward to broader deployment of genomic profiling.
Schram AM; Berger MF; Hyman DM
PLoS Med; 2017 Feb; 14(2):e1002242. PubMed ID: 28222135
[TBL] [Abstract][Full Text] [Related]
18. Physician interpretation of genomic test results and treatment selection.
Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
[TBL] [Abstract][Full Text] [Related]
19. Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.
Hamilton JG; Shuk E; Genoff MC; Rodríguez VM; Hay JL; Offit K; Robson ME
J Oncol Pract; 2017 Jul; 13(7):e590-e601. PubMed ID: 28628391
[TBL] [Abstract][Full Text] [Related]
20. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis GJ; Coleman WB
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
